Applications for the G4A Global Accelerator Are Now Open

Founded in 2013 in Berlin initially giving out grants to innovative healthcare apps, G4A Accelerator is now a global program dedicated to helping innovative health & care startups grow and enable positive disruption and progress within the digital health & care universe.

G4A Global Accelerator has two programs currently running for startups and companies. Join and change the experience of healthcare today. Accelerator applications close on May 31st!

G4A Accelerator

The 2018 Accelerator program aims to offer mentoring by entrepreneurs and Bayer experts, office space for 100 days, funding of 50,000€, and exclusive networking opportunities for your startup.

Over 100 Bayer experts are involved in the jury process to decide which companies Bayer will work with. Criteria of acceptance into the program include: company maturity, existing product prototypes, the team, as well as the applicant's fit to Bayer's areas of expertise and focus areas.

For further information and to apply, please visit:
https://bayer.agorize.com/en/challenges/g4a-global-accelerator-2018

G4A Dealmaker

The 2018 Dealmaker program is tailored for mature startups and companies that have a solution ready to go. The new Dealmaker is all about quality facetime between you and G4A experts for one full day. If there is a match, you will be invited to Berlin to pitch your solution, discuss collaboration options and close a deal. Travel stipends included!

For further information and to apply, please visit:
https://bayer.agorize.com/en/challenges/g4a-global-dealmaker-2018

Most Popular Now

Research Shows AI Technology Improves Pa…

Existing research indicates that the accuracy of a Parkinson's disease diagnosis hovers between 55% and 78% in the first five years of assessment. That's partly because Parkinson's sibling movement disorders...

Who's to Blame When AI Makes a Medi…

Assistive artificial intelligence technologies hold significant promise for transforming health care by aiding physicians in diagnosing, managing, and treating patients. However, the current trend of assistive AI implementation could actually...

First Therapy Chatbot Trial Shows AI can…

Dartmouth researchers conducted the first clinical trial of a therapy chatbot powered by generative AI and found that the software resulted in significant improvements in participants' symptoms, according to results...

DMEA sparks: The Future of Digital Healt…

8 - 10 April 2025, Berlin, Germany. Digitalization is considered one of the key strategies for addressing the shortage of skilled workers - but the digital health sector also needs qualified...

DeepSeek: The "Watson" to Doct…

DeepSeek is an artificial intelligence (AI) platform built on deep learning and natural language processing (NLP) technologies. Its core products include the DeepSeek-R1 and DeepSeek-V3 models. Leveraging an efficient Mixture...

Stepping Hill Hospital Announced as SPAR…

Stepping Hill Hospital, part of Stockport NHS Foundation Trust, has replaced its bedside units with state-of-the art devices running a full range of information, engagement, communications and productivity apps, to...

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...